Clinical Trials

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

Sitting Down With… Gen Li, CEO, Phesi

Why conversations on gender in drug development must go further.

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Insights into the quest to find an effective treatment for this socially painful condition

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Is now finally the time for Alzheimer’s drug development to shine?

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy